Sort
40,608 grants matching “prostate cancer”
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
$344,269Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2016 · CA
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
$344,269Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2018 · CA
Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin
$344,269Vivek M Rangnekar · University Of Kentucky · R01 · FY2017 · CA
Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin
$344,269Vivek M Rangnekar · University Of Kentucky · R01 · FY2018 · CA
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
$344,269Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2015 · CA
Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin
$344,269Vivek M Rangnekar · University Of Kentucky · R01 · FY2016 · CA
Polymeric nanoparticles with imaging capability for therapeutic peptide delivery
$344,267J Manuel Perez · University Of Central Florida · R01 · FY2014 · EB
A NOVEL ANTI-BETA2-MICROGLOBULIN ANTIBODY INHIBITION OF ANDROGEN RECEPTOR EXPRESSION, SURVIVAL AND PROGRESSION IN PROSTATE CANCER CELLS
$344,250Emory University · · FY2008 · Department of the Army
METASTATIC PROSTATE CANCER THERAPY BYE A NOVEL SINGLE AGENT SYNERGISTIC COMBINATIONS WITH TAXOTERE
$344,250Georgia State University Research Foundation Inc · · FY2008 · Department of the Army
Phototherapy of Prostate Cancer-Pro and Anti Apoptosis
$344,250Case Western Reserve University · R01 · FY2005 · CA
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM
$344,250Cedars-Sinai Medical Center · R01 · FY2004 · DK
Phototherapy of Prostate Cancer-Pro and Anti Apoptosis
$344,250Case Western Reserve University · R01 · FY2004 · CA
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM
$344,250Cedars-Sinai Medical Center · R01 · FY2003 · DK
Phototherapy of Prostate Cancer-Pro and Anti Apoptosis
$344,250Case Western Reserve University · R01 · FY2003 · CA
Post-translational regulation of CYP17 activity
$344,207Cedars-Sinai Medical Center · R01 · FY2005 · HD
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer
$344,170Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer
$344,168Lloyd M Smith · University Of Wisconsin-Madison · R01 · FY2015 · CA
Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer
$344,168Lloyd M Smith · University Of Wisconsin-Madison · R01 · FY2017 · CA
Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer
$344,168Lloyd M Smith · University Of Wisconsin-Madison · R01 · FY2016 · CA
Real-time prostate lesion tracking during SBRT
$344,156Jing Wang · Ut Southwestern Medical Center · R01 · FY2021 · EB
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression
$344,142Jay H Fowke · Vanderbilt University · R01 · FY2012 · DK
Phytotherapy for Benign Prostatic Hyperplasia
$344,140Andrew L Avins · Kaiser Foundation Research Institute · U01 · FY2009 · DK
Highly Paramagnetic, Biodegradable Nanoclusters for Imaging Prostate Cancer
$344,137Andrew Tsourkas · University Of Pennsylvania · R01 · FY2011 · CA
Modulating HSP70/STUB1 machinery in therapy-resistant prostate cancer
$344,129Chengfei Liu · University Of California At Davis · R01 · FY2024 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness
$344,109Alan Pollack · University Of Miami School Of Medicine · U01 · FY2023 · CA